A5058209970- Cardiovascular Function and Risk Factors
- Antiplatelet Therapy and Cardiovascular Diseases
- Colorectal Cancer Screening and Detection
- Innovations in Medical Education
- Pelvic floor disorders treatments
- Atrial Fibrillation Management and Outcomes
- Urinary Tract Infections Management
- Venous Thromboembolism Diagnosis and Management
- Clinical Reasoning and Diagnostic Skills
- Heart Failure Treatment and Management
- Empathy and Medical Education
- Cardiac pacing and defibrillation studies
Stanford University
2019-2024
Stanford Medicine
2022
Sacubitril/valsartan (Entresto) has proven therapeutic effects in heart failure (HF) patients, but its impact on those with advanced chronic kidney disease (CKD) remains unclear, particularly HF patients coexisting end-stage renal (ESRD). This study aims to assess the long-term survival of reduced ejection fraction (HFrEF) and ESRD treated sacubitril/valsartan. A retrospective cohort included 2,860 HFrEF between January 2008 December 2020. After propensity score matching, data from a...
Our website uses cookies to enhance your experience. By continuing use our site, or clicking "Continue," you are agreeing Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications Network Open Cardiology Dermatology Health Forum Internal Medicine Neurology Oncology Ophthalmology Otolaryngology–Head & Neck Surgery Pediatrics Psychiatry Archives of (1919-1959) JN Learning /...
In primary care clinics, time constraints and lack of exposure to highly complex cases may limit the breadth depth learning for internal medicine residents. To address these issues, we piloted a novel experience residents evaluate patients with puzzling symptoms referred by another clinician.To increase residents' perplexing presentations foster team-based approach solving diagnostically challenging cases.During academic year 2020-2021, participating in their 2-week "block" rotation were...